Laboratory Evaluation for Fatigue
Order a core panel of laboratory tests for all patients presenting with fatigue, including: complete blood count with differential, comprehensive metabolic panel (electrolytes, BUN, creatinine, liver function tests), thyroid-stimulating hormone (TSH), urinalysis, fasting glucose or HbA1c, and inflammatory markers (ESR/CRP). 1, 2
Initial Screening and Quantification
- Use a 0-10 numeric rating scale to quantify fatigue severity before ordering labs: mild (1-3), moderate (4-6), severe (7-10) 3, 2
- Patients scoring ≥4 require comprehensive laboratory evaluation and focused assessment 3
- Screen for concurrent symptoms (pain, sleep disturbance, emotional distress) as fatigue rarely occurs in isolation 3, 2
Core Laboratory Panel (Order for All Patients)
Hematologic Assessment
- Complete blood count (CBC) with differential to detect anemia, infection, or hematologic malignancy 3, 1, 2
- Include red cell indices (MCV, RDW) and reticulocyte count to characterize anemia type 2
- Compare current hemoglobin/hematocrit to baseline values if available 3
Metabolic and Renal Function
- Comprehensive metabolic panel including electrolytes (sodium, potassium, chloride, bicarbonate), calcium, and magnesium 3, 1, 2
- Blood urea nitrogen (BUN) and serum creatinine to assess kidney function 3, 1, 2
- Liver function tests (AST, ALT, alkaline phosphatase, bilirubin) to evaluate hepatic disorders 3, 1, 2
Endocrine Screening
- Thyroid-stimulating hormone (TSH) is essential as hypothyroidism is a highly treatable cause of fatigue 3, 1, 2
- Consider more comprehensive endocrine evaluation if other symptoms suggest dysfunction (diabetes screening with fasting glucose or HbA1c) 3, 1, 2
Additional Core Tests
- Urinalysis for protein, blood, and glucose to screen for renal disease or infection 3, 1, 2
- Inflammatory markers (ESR and/or CRP) to identify underlying inflammatory conditions 3, 2
- Fasting lipid profile to assess cardiovascular risk 1
Extended Laboratory Evaluation for Moderate-to-Severe Fatigue (Score ≥4)
Iron Studies and Nutritional Assessment
- Serum ferritin and transferrin saturation to assess iron stores, particularly important as low iron can cause fatigue even without anemia 3, 2
- Vitamin B12 and folate levels to identify deficiencies 2
- 25-OH vitamin D level, especially in patients with chronic disease or limited sun exposure 3
Hemolysis Evaluation (If Anemia Present)
- Haptoglobin, lactate dehydrogenase (LDH), and indirect bilirubin if hemolytic anemia suspected 2
- Percentage of hypochromic red cells and reticulocyte hemoglobin for detailed iron assessment 2
- Soluble transferrin receptor for accurate iron deficiency assessment in inflammatory states 2
Context-Specific Laboratory Testing
Cancer Patients or Survivors
- Evaluate disease status and risk of recurrence based on treatment history 3
- Consider more extensive workup if fatigue begins or worsens >6-12 months post-treatment, or if accompanied by weight loss, pain, or other concerning symptoms 3
- Screen for treatment-related complications: TSH if neck/thoracic radiation received, cardiac biomarkers if cardiotoxic therapy given 3
Cardiac Disease Suspicion
- B-type natriuretic peptide (BNP) or NT-proBNP if heart failure suspected 1, 2
- Consider echocardiogram for patients with history of cardiotoxic treatments 3
Inflammatory Conditions
- Elevated inflammatory markers warrant investigation for underlying inflammatory or autoimmune disease 3, 2
- Consider disease-specific testing based on clinical presentation 3
Critical Interpretation Points
Laboratory results directly affect management in only ~5% of fatigue cases, but testing remains essential to identify treatable causes. 4 The primary value is ruling out serious underlying conditions rather than confirming a specific diagnosis.
Key Findings That Require Action
- Anemia: Persistently low hemoglobin or iron stores are reversible causes requiring treatment even in absence of bowel symptoms 3
- Thyroid dysfunction: Hypothyroidism is highly prevalent and completely treatable 3
- Electrolyte disturbances: Abnormalities in calcium, magnesium, or other electrolytes require correction 3, 1
- Renal or hepatic dysfunction: Abnormal kidney or liver function may explain fatigue and guide further evaluation 3, 1
- Elevated inflammatory markers without clear source: May indicate occult malignancy, infection, or autoimmune disease requiring investigation 3
Common Pitfalls to Avoid
- Do not repeat normal laboratory tests without clinical indication—if initial comprehensive workup is unrevealing, repeat testing rarely provides new information 4
- Do not attribute all fatigue to "stress" or "depression" without completing objective laboratory evaluation to exclude medical causes 3
- Do not overlook iron deficiency in the absence of anemia—low ferritin alone can cause significant fatigue 3, 2
- Do not fail to assess disease recurrence in cancer survivors—new or worsening fatigue may herald recurrent malignancy 3
- Do not order excessive specialized testing initially—focus on the core panel first, then expand based on clinical findings 4
Follow-Up Strategy
- Re-screen fatigue severity after treating any identified abnormalities (correct anemia, optimize thyroid function, address electrolyte imbalances) 3, 2
- If comprehensive laboratory evaluation is normal but moderate-to-severe fatigue persists, shift focus to non-laboratory causes: sleep disorders, depression/anxiety, deconditioning, medications, or primary fatigue syndromes 3
- Schedule regular follow-up visits rather than sporadic appointments for effective long-term management 4